Kezar Life Sciences: Mid-Term Growth Levers Heavily Discounted, Hold (KZR)
staticnak1983 Investment Summary The investment debate for Kezar Life Sciences, Inc. (NASDAQ:KZR) has changed drastically since my last rating on the company. Clinical trial and regulatory tailwinds were previous catalysts for KZR. However, the market […]
